Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

FromKeeping Current CME


Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

FromKeeping Current CME

ratings:
Length:
18 minutes
Released:
Dec 14, 2023
Format:
Podcast episode

Description

Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing? Credit available for this activity expires: 12/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu
Released:
Dec 14, 2023
Format:
Podcast episode

Titles in the series (100)

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.